Speaker illustration

Doctor Anton Borisov

National Medical Research Center for Cardiology, Moscow (Russian Federation)

Effects of empagliflozin on exercise capacity and LV diastolic function in HFpEF and type-2 diabetes mellitus: rationale and design of prospective intervention study

Event: Heart Failure 2019

Topic: Pharmacotherapy

Session: Chronic Heart Failure – Treatment


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb